Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-17T14:14:58.122Z Has data issue: false hasContentIssue false

Endogenous Depression Treated with Iproniazid—A Follow-Up Study

Published online by Cambridge University Press:  08 February 2018

L. G. Kiloh
Affiliation:
Department of Psychological Medicine, University of Durham
J. P. Child
Affiliation:
St. Nicholas' Hospital, Newcastle upon Tyne
G. Latner
Affiliation:
St. Nicholas' Hospital, Newcastle upon Tyne
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

A double-blind controlled trial of iproniazid in endogenous depression and a comparison of its effects with those of E.C.T. was reported in this journal by Kiloh et al. (1960). To summarize the results—of 26 patients treated with iproniazid a good immediate response was found in 14 cases (54 per cent.) whereas only 3 of 28 patients (11 per cent.) given placebo tablets showed a significant improvement at the end of three weeks. Of 27 patients treated with E.C.T. 24 (89 per cent.) showed a good immediate response.

Information

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1960 
Submit a response

eLetters

No eLetters have been published for this article.